爱尔康(ALC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALC 爱尔康

未开盘 05-09 16:00:00 EDT

81.46

+1.11

+1.38%

盘后81.46

+0.000.00%

16:00 EDT

最高81.72	最低80.63	成交量67.15万
今开80.63	昨收80.35	日振幅1.36%
总市值401.80亿	流通市值401.01亿	总股本4.93亿
成交额5,470万	换手率0.14%	流通股本4.92亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALC","market":"US","secType":"STK","nameCN":"爱尔康","latestPrice":81.46,"timestamp":1715284800000,"preClose":80.35,"halted":0,"volume":671487,"hourTrading":{"tag":"盘后","latestPrice":81.46,"preClose":81.46,"latestTime":"16:00 EDT","volume":28797,"amount":2345803.62,"timestamp":1715284858759},"delay":0,"floatShares":492281369,"shares":493244479,"eps":1.96,"marketStatus":"未开盘","marketStatusCode":0,"change":1.11,"latestTime":"05-09 16:00:00 EDT","open":80.63,"high":81.72,"low":80.63,"amount":54698733.39657,"amplitude":0.013566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.96,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715328000000},"adr":0,"adjPreClose":80.35,"adrRate":0,"dividendRate":0.003499,"preHourTrading":{"tag":"盘前","latestPrice":80.35,"preClose":80.35,"latestTime":"08:30 EDT","volume":1,"amount":80.35,"timestamp":1715257823092},"postHourTrading":{"tag":"盘后","latestPrice":81.46,"preClose":81.46,"latestTime":"16:00 EDT","volume":28797,"amount":2345803.62,"timestamp":1715284858759},"volumeRatio":1.032223},"requestUrl":"/m/hq/s/ALC","defaultTab":"news","newsList":[{"id":"2416113663","title":"卷王朱江明，为什么总爱“上价值”","url":"https://stock-news.laohu8.com/highlight/detail?id=2416113663","media":"超电实验室","top":-1,"share":"https://www.laohu8.com/m/news/2416113663?lang=zh_cn&edition=full","pubTime":"2024-03-04 18:35","pubTimestamp":1709548512,"startTime":"0","endTime":"0","summary":"零跑的做法，是 “上价值”。3月2日，零跑发布首款全球车型C10，增程版13.58万起，纯电版12.88万起，分别比预售价低了1.6万、2.7万。价格战，终于卷向了“价值战”。现在我们来看一下，售价在15万级的零跑C10，都具备哪些 “价值标准” 。C10车身长度是4739mm，轴距为2825mm，车身尺寸相当于中型SUV，定位虽然只比理想L7低一个级别，但价格直接“腰斩”，比后者便宜一半还要多。不过在朱江明看来， 零跑的竞争对手并不是比亚迪。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8XgFsxxRF2f","is_publish_highlight":false,"gpt_icon":0},{"id":"2416629909","title":"爱尔康2023财年实现净利润9.74亿美元，同比增加190.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416629909","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416629909?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:16","pubTimestamp":1709482582,"startTime":"0","endTime":"0","summary":"12月31日，爱尔康公布财报，公告显示公司2023财年净利润为9.74亿美元，同比增加190.75%；其中营业收入为94.55亿美元，同比增加8.47%，每股基本收益为1.98美元。机构评级：截至2023年12月31日，当前有25家机构对爱尔康目标价做出预测，其中目标均价为91.59美元，其中最低目标价为65.00美元，最高目标价为104.00美元。爱尔康拥有世界上最大的眼科手术设备安装基地之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040016278afdcf81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040016278afdcf81&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415758843","title":"爱尔康盘中异动 早盘快速拉升5.03%报85.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415758843","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415758843?lang=zh_cn&edition=full","pubTime":"2024-02-28 23:08","pubTimestamp":1709132916,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日23时08分，爱尔康股票出现波动，股价急速拉升5.03%。截至发稿，该股报85.26美元/股，成交量68.9557万股，换手率0.14%，振幅1.99%。最近的财报数据显示，该股实现营业收入94.55亿美元，净利润9.74亿美元，每股收益1.98美元，毛利59.22亿美元，市盈率93.64倍。爱尔康股票所在的医疗设备行业中，整体跌幅为0.03%。爱尔康公司简介：爱尔康是全球领先的视力保健公司之一。爱尔康拥有世界上最大的眼科手术设备安装基地之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240228230836861d9a9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240228230836861d9a9e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2403078063","title":"投行Baird看好2024年医疗技术股跑赢大盘，首选爱尔康(ALC.US)和波士顿科学(BSX.US)等公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2403078063","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2403078063?lang=zh_cn&edition=full","pubTime":"2024-01-16 07:10","pubTimestamp":1705360200,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，投行Baird表示，在经历了三年的表现不佳之后，预计医疗科技股将在2024年跑赢大盘，但对牙科和美容市场近期仍持谨慎态度。Baird说，正因为如此，它正在改变对牙科群体的看法，从“战术上的积极到战术上的中立，甚至稍微消极”。尽管如此，Baird提醒InMode的投资者“做好准备，2024年的最终指引可能会要求今年的收入相对于2023年几乎没有增长。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011607130987bea0ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011607130987bea0ae&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2394111957","title":"爱尔康集采杀价震惊业内，高端人工晶体从2.3万降至9000元后与海外平价","url":"https://stock-news.laohu8.com/highlight/detail?id=2394111957","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2394111957?lang=zh_cn&edition=full","pubTime":"2023-12-28 19:13","pubTimestamp":1703762030,"startTime":"0","endTime":"0","summary":"爱尔康降价后三焦点人工晶体比主要竞争对手之一的蔡司低40%，双焦点人工晶体至比国产的爱博诺德低约1000元，或将颠覆国内人工晶体市场，行业格局有望迎来大洗牌。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/14a283a3-3faf-4481-a14d-ce03087d57b7.png?imageView2/1/w/340/h/340","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/14a283a3-3faf-4481-a14d-ce03087d57b7.png?imageView2/1/w/340/h/340"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3705228","is_publish_highlight":false,"gpt_icon":0},{"id":"2394798863","title":"眼科龙头爱尔康高端人工晶体集采价格大跳水，双焦点产品比国产品牌低约千元","url":"https://stock-news.laohu8.com/highlight/detail?id=2394798863","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2394798863?lang=zh_cn&edition=full","pubTime":"2023-12-28 13:03","pubTimestamp":1703739815,"startTime":"0","endTime":"0","summary":"每经记者：李宣璋每经编辑：陈旭每经讯 第四批高值耗材集采结果震惊业界：爱尔康作为全球眼科龙头，将自家三焦点人工晶体价格从2.3万元降至8996元，这一价格比主要竞争对手之一的蔡司低40%！在双焦点人工晶体方面，爱尔康的报价也成为全场最低。作为进口品牌，其1796元的价格，甚至比国产的爱博诺德还低了约1000元。每日经济新闻","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231228130413818291f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231228130413818291f7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2394249492","title":"投行Baird评出2024年医疗技术首选 看好爱尔康和Axonics","url":"https://stock-news.laohu8.com/highlight/detail?id=2394249492","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2394249492?lang=zh_cn&edition=full","pubTime":"2023-12-26 21:13","pubTimestamp":1703596439,"startTime":"0","endTime":"0","summary":"出于类似的原因，Baird也看好隐形眼镜制造商库柏，但相比库柏外科，Baird更看好爱尔康的外科。Baird认为，爱尔康2024年的利润率扩张幅度将大于库珀。至于波士顿科学，Baird认为新产品的推出将推动公司收入在2025年加速增长，因此利润率的提高将提升估值。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2023/12/26211338887376.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2394382542","title":"投行Baird评出2024年医疗技术首选，看好爱尔康(ALC.US)和Axonics(AXNX.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2394382542","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2394382542?lang=zh_cn&edition=full","pubTime":"2023-12-25 08:00","pubTimestamp":1703462428,"startTime":"0","endTime":"0","summary":"投行Baird评出2024年医疗技术首选，看好爱尔康和Axonics智通财经APP获悉，投行Baird选择爱尔康、史赛克、库珀医疗、Axonics和波士顿科学作为其2024年的首选医疗科技股。出于类似的原因，Baird也看好隐形眼镜制造商库柏，但相比库柏外科，Baird更看好爱尔康的外科。Baird认为，爱尔康2024年的利润率扩张幅度将大于库珀。Baird表示，Inspire Medical Systems和Intuitive Surgical因估值和“近期潜在负面新闻风险”落选其首选名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1044774.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2391412300","title":"爱尔康全国首台睑板腺光热脉动治疗仪入驻华厦眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2391412300","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2391412300?lang=zh_cn&edition=full","pubTime":"2023-12-13 08:30","pubTimestamp":1702427400,"startTime":"0","endTime":"0","summary":"12月9日，华厦眼科医院集团MGD诊疗学术交流会暨爱来视上市会在厦门成功举办，爱尔康全国首台爱来视睑板腺光热脉动V.I.P．复合治疗仪在厦门眼科中心正式投入临床使用。这标志着华厦眼科将引领开启干眼诊疗新时代，加速全民“眼健康生态圈”的建设进程。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/enterprise/2023-12-13/doc-imzxucmx3317402.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/2023-12-13/doc-imzxucmx3317402.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2388296559","title":"极氪009车型推送OS 4.2，新增ALC拨杆变道、DOW开门预警等功能","url":"https://stock-news.laohu8.com/highlight/detail?id=2388296559","media":"IT之家","top":-1,"share":"https://www.laohu8.com/m/news/2388296559?lang=zh_cn&edition=full","pubTime":"2023-12-02 12:11","pubTimestamp":1701490261,"startTime":"0","endTime":"0","summary":"IT之家 12 月 2 日消息，极氪汽车宣布极氪 009 OS 4.2 正式开启推送 ，新增 ALC 拨杆变道、DOW 开门预警功能，优化 One-pedal 单踏板驾驶模式、驻车舒享等。IT之家附更新内容：ALC 拨杆变道通畅高速公路以及城市快速路上，在全速域主动巡航基础上开启该功能，只需拨动转向灯拨杆，车辆即可按照指令在一定条件下辅助进行车道变换。DOW 开门预警当打开车门时，若车辆侧后方盲区内有移动目标靠近，车辆将通过提示音、盲区指示灯闪烁等方式提醒用户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8VBZ6SMpuKE","is_publish_highlight":false,"gpt_icon":0},{"id":"2388284303","title":"爱尔康：人工晶体国采会推动更多患者从选择简单产品转变到选择高端产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2388284303","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2388284303?lang=zh_cn&edition=full","pubTime":"2023-12-01 16:18","pubTimestamp":1701418700,"startTime":"0","endTime":"0","summary":"每经记者：李宣璋每经编辑：陈旭每经讯 11月30日，第四批国家组织高值医用耗材集中带量采购在天津开标。本次集采，人工晶体成为各界关注的重点，其中，高端人工晶体又是国内外企业角逐的关键。在集采现场，爱尔康（中国）眼科产品有限公司全国销售总监杨斌接受《每日经济新闻》记者专访时表示，本次集采会推动国内人工晶体市场从低端向高端转型。相信集采以后，有很多患者会从选择最简单的产品转变到选择高端的产品。如果条件允许的患者能够植入高端人工晶体，这些患者将大大受益，在眼科低压区，作为生产商方面就可以提供更多的选择项。每日经济新闻","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120116184583c3bfef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120116184583c3bfef&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2387490383","title":"人工晶体国采拟中选结果公布：爱博诺德、爱尔康等企业产品均拟中选","url":"https://stock-news.laohu8.com/highlight/detail?id=2387490383","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2387490383?lang=zh_cn&edition=full","pubTime":"2023-11-30 14:33","pubTimestamp":1701326011,"startTime":"0","endTime":"0","summary":"每经记者：李宣璋每经编辑：陈旭每经讯 11月30日，第四批国家组织医用耗材集中带量采购拟中标结果公布。在人工晶体类别，单焦点、双焦点、三焦点、景深延长等产品均有多家企业拟中选。《每日经济新闻》记者注意到，在中高端人工晶体方面，爱尔康、爱博诺德、上药控股等企业的产品均拟中选。爱尔康（中国）眼科产品有限公司全国销售总监杨斌接受《每日经济新闻》记者采访时表示，本次爱尔康人工晶体全品类产品均拟中选，其中价格降幅最大的是三焦点人工晶体。爱博诺德负责人告诉《每日经济新闻》记者，本次公司参与集采的产品均拟中选。每日经济新闻","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231130143358821c3e7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231130143358821c3e7a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2384371076","title":"爱尔康2023财年第三财季实现净利润2.04亿美元，同比增加75.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2384371076","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2384371076?lang=zh_cn&edition=full","pubTime":"2023-11-20 00:18","pubTimestamp":1700410709,"startTime":"0","endTime":"0","summary":"9月30日，爱尔康公布财报，公告显示公司2023财年第三财季净利润为2.04亿美元，同比增加75.86%；其中营业收入为23.29亿美元，同比增加8.83%，每股基本收益为0.41美元。机构评级：截至2023年9月30日，当前有21家机构对爱尔康目标价做出预测，其中目标均价为89.92美元，其中最低目标价为73.32美元，最高目标价为104.05美元。爱尔康拥有世界上最大的眼科手术设备安装基地之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231120001832842994f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231120001832842994f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2383185946","title":"爱尔康盘中异动 早盘股价大跌6.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2383185946","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2383185946?lang=zh_cn&edition=full","pubTime":"2023-11-15 22:32","pubTimestamp":1700058724,"startTime":"0","endTime":"0","summary":"北京时间2023年11月15日22时32分，爱尔康股票出现异动，股价快速跳水6.76%。截至发稿，该股报69.90美元/股，成交量17.7976万股，换手率0.04%，振幅1.44%。爱尔康股票所在的医疗设备行业中，整体跌幅为0.16%。其相关个股中，Femasys Inc、Predictive Oncology Inc、Sanara Medtech Inc涨幅较大，Femasys Inc、登士柏、Singular Genomics Systems Inc较为活跃，换手率分别为6.79%、0.22%、0.17%，振幅较大的相关个股有Femasys Inc、Zentek Ltd、Sanara Medtech Inc，振幅分别为16.13%、5.31%、4.46%。爱尔康拥有世界上最大的眼科手术设备安装基地之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311152232058279145c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311152232058279145c&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alcon.com","stockEarnings":[{"period":"1week","weight":0.0388},{"period":"1month","weight":-0.0148},{"period":"3month","weight":0.0552},{"period":"6month","weight":0.1177},{"period":"1year","weight":0.0102},{"period":"ytd","weight":0.0428}],"compareEarnings":[{"period":"1week","weight":0.03},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0378},{"period":"6month","weight":0.1806},{"period":"1year","weight":0.2599},{"period":"ytd","weight":0.0944}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alcon Inc.最初于1971年在瑞士注册成立。Alcon是一家以研发为主导的全球医疗专业公司，主要专注于眼部护理。该公司开发，生产和销售药品，手术设备和设备以及消费者眼部护理产品。该公司广泛的产品系列是眼科行业中最强大的产品组合之一，在所有主要产品类别中都拥有高质量和技术先进的产品。该公司相信它拥有全球任何公司眼科研究和开发的最大承诺。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.013735},{"month":2,"riseRate":0.6,"avgChangeRate":0.005925},{"month":3,"riseRate":0.6,"avgChangeRate":-0.019148},{"month":4,"riseRate":0.6,"avgChangeRate":-0.005889},{"month":5,"riseRate":0.666667,"avgChangeRate":0.048966},{"month":6,"riseRate":0.6,"avgChangeRate":-0.005365},{"month":7,"riseRate":0.8,"avgChangeRate":0.036185},{"month":8,"riseRate":0.4,"avgChangeRate":-0.011043},{"month":9,"riseRate":0,"avgChangeRate":-0.052099},{"month":10,"riseRate":0.6,"avgChangeRate":0.003855},{"month":11,"riseRate":0.6,"avgChangeRate":0.039784},{"month":12,"riseRate":0.8,"avgChangeRate":0.037954}],"exchange":"NYSE","name":"爱尔康","nameEN":"Alcon Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔康(ALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔康(ALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔康,ALC,爱尔康股票,爱尔康股票老虎,爱尔康股票老虎国际,爱尔康行情,爱尔康股票行情,爱尔康股价,爱尔康股市,爱尔康股票价格,爱尔康股票交易,爱尔康股票购买,爱尔康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔康(ALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔康(ALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}